Vendor, Lawrenceville, GA, part of Cipla USA Inc.
Xlcare Pharmaceuticals Inc.
UEI MEAUS5WHBJJ7, CAGE 86SL9
20 awards and $0 obligated between January 9, 2024 and September 3, 2026, 100% under full and open competition, against 103.9 offers on average where reported. 35 of the awards trace back to a SAM.gov solicitation on this site.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 20 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- XLCare Pharmaceuticals, Inc. (June 1, 2026 - May 31, 2031
Department of Veterans Affairs, Nac Federal Supply Schedule
Award noticeNAICS 32541236F79726D0120Awarded to Xlcare Pharmaceuticals Inc. for $50,000,000
Posted May 6 - Allopurinol Tablets Effective May 30, 2026 to May 29, 2027
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79725R0067Awarded to Xlcare Pharmaceuticals Inc. for $17,786,862
Posted Mar 94 publications - Levetiracetam Tablets
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79726R0001Awarded to Xlcare Pharmaceuticals Inc. for $9,568,741
Posted Feb 114 publications - Carbidopa Levodopa Immediate Release (IR) Tablets
Department of Veterans Affairs, Nac Pharmaceuticals
SolicitationNAICS 32541236E79726R0008Awarded to Xlcare Pharmaceuticals Inc.
Posted Jan 223 publications - Montelukast 10mg Tablet
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79725R0061Awarded to Xlcare Pharmaceuticals Inc. for $24,826,671
Posted Jan 95 publications - Losartan Tablets
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79725R0032Awarded to Xlcare Pharmaceuticals Inc. for $37,933,103
Posted Jul 3, 20253 publications - Topiramate Tablets
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79725R0031Awarded to Xlcare Pharmaceuticals Inc. for $14,134,788
Posted Jun 26, 20259 publications - Levothyroxine Tablets XLCare Pharmaceuticals, Inc. Base Year Ordering Period: 1/27/2025 - 1/26/2026
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79724R0020Awarded to Xlcare Pharmaceuticals Inc. for $40,144,392
Posted Nov 27, 20243 publications - Oxcarbazepine RFP
Department of Veterans Affairs, Nac Pharmaceuticals
SolicitationNAICS 32541236E79724R0021Awarded to Xlcare Pharmaceuticals Inc.
Posted Jul 2, 20242 publications - Methocarbamol Tablets
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79724R0005Awarded to Xlcare Pharmaceuticals Inc. for $11,608,274
Posted Jan 25, 2024
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36E79720D0038February 28, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Change Timeframe for the Submission of Quarterly Sales Reports and Cost Recovery Fee to 30 Calendar Days After End of Each Fiscal Quarter.NAICS 325412, PSC 6505 | $0 |
| 36E79720D0049March 28, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF Payment and Sales Reporting UpdatesNAICS 325412, PSC 6505 | $0 |
| 36E79720D0073January 9, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Exercising Option Year 3 of 36E79720D0073NAICS 325412, PSC 6505 | $0 |
| 36E79721D0027February 9, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Cost Recovery Fee and Submission of Quarterly Sales Reports Changes Effective 2/9/2024 for Montelukast Na Tablets with Xlcare PharmaceuticalNAICS 325412, PSC 6505 | $0 |
| 36E79721D0031February 7, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | 52.212-4(C) Contract Terms and Conditions - Changes Update to Cost Recovery Fee (Crf) and Submission of Quarterly Sales Reports 36E79721D003NAICS 325412, PSC 6505 | $0 |
| 36E79721D0051April 15, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Cost Recovery Fee ChangeNAICS 325412, PSC 6505 | $0 |
| 36E79722D0023February 20, 2024, Full and Open Competition, 5 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | This Modification Is Issued to Update the Terms of the CRF Payment Remittal and Submission of Quarterly Sales Reports.NAICS 325412, PSC 6505 | $0 |
| 36E79723D0018March 28, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF Sales Submittal and Reporting ChangesNAICS 325412, PSC 6505 | $0 |
| 36E79723D0027February 9, 2024, Full and Open Competition, 7 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Cost Recovery Fee and Submission of Quarterly Sales Report Changes Effective 2/9/2024 for Gabapentin Capsules with Xlcare Pharmaceuticals, INAICS 325412, PSC 6505 | $0 |
| 36E79724D0018January 24, 2024, Full and Open Competition, 8 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | Award to Xlcare Pharmaceuticals for Methocarbamol Tablets for the Base Year with Four ONE-YEAR Options.NAICS 325412, PSC 6505 | $0 |
| 36E79724D0034August 15, 2024, Full and Open Competition, 3 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | New Award for Oxcarbazepine with Xlcare Pharmaceuticals. Period of Performance Is Oct 14, 2024 to Oct 13, 2025 with Four ONE-YEAR OptionsNAICS 325412, PSC 6505 | $0 |
| 36E79725D0004November 27, 2024, Full and Open Competition, 3 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | New Award for Levothyroxine Na Tablets with Xlcare Pharmaceuticals, INC. Base Year Ordering Period Is Jan 27, 2025 Through Jan 26, 2026 withNAICS 325412, PSC 6505 | $0 |
| 36E79725D0037July 2, 2025, Full and Open Competition, 8 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | New Award for Losartan Tablets with Xlcare Pharmaceuticals, INC. Period of Performance Is 9/24/2025-9/23/2026.NAICS 325412, PSC 6505 | $0 |
| 36E79725D0045June 26, 2025, Full and Open Competition, 7 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | New Award for Topiramate Tablets with Xlcare. Ordering Period Is Oct 31, 2025 to Oct 30, 2026 with Four ONE-YEAR Options.NAICS 325412, PSC 6505 | $0 |
| 36E79726D0007January 8, 2026, Full and Open Competition, 2 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | 3 Line Items for Montelukast 10MG Tablet. Awarded for a Base Year of 5/10/2026 to 5/9/2027 Plus 4 ONE-YEAR Option Periods.NAICS 325412, PSC 6505 | $0 |
| 36E79726D0019February 5, 2026, Full and Open Competition, 5 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | New Award for Levetiracetam Tablets with Xlcare Pharmaceuticals. Ordering Period Feb 5, 2026 to May 23, 2026, with Four ONE-YEAR Options.NAICS 325412, PSC 6505 | $0 |
| 36E79726D0024March 9, 2026, Full and Open Competition, 7 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | New Award for Allopurinol Tablets with Xlcare Pharmaceuticals, INC. Ordering Period Is May 30, 2026 to May 29, 2027 with Four ONE-YEAR OptioNAICS 325412, PSC 6505 | $0 |
| 36E79726D0027March 27, 2026, Full and Open Competition, 4 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | New Award for Carbidopa/Levodopa Immediate-Release (Ir) Tablets with Xlcare Pharmaceuticals, INC. Ordering Period Is June 21, 2026 to June 2NAICS 325412, PSC 6505 | $0 |
| 36F79721D0091January 12, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | Temporary Price DecreaseNAICS 325412, PSC 6505 | $0 |
| 36F79726D0120May 6, 2026, Full and Open Competition, 999 offersSolicitation | Nac Federal Supply ScheduleDepartment of Veterans Affairs | 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract AwardNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 168 across 20 awards